LATUDA tablets are intended for oral administration only. Each tablet contains 20 mg, 40 mg, 60 mg, 80 mg, or 120 mg of lurasidone hydrochloride. Inactive ingredients are mannitol, pregelatinized starch, croscarmellose sodium, hypromellose, magnesium stearate, Opadry®and carnauba wax. Additionally,...
Tablet Strength Tablet Color/Shape Tablet Markings 20 mg white to off-white round L20 40 mg white to off-white round L40 60 mg white to off-white oblong L60 80 mg pale green oval L80 120 mg white to off-white oval L120 4. Contraindications Known hypersensitivity to lurasidone HCl...
"l 120". latuda 40 mg tablet color: white shape: round imprint: l 40 this medicine is a white, oval, tablet imprinted with "l 120". latuda 60 mg tablet color: white shape: oblong imprint: l 60 this medicine is a white, oval, tablet imprinted with "l 120". latuda 20 mg tablet ...
Latuda is an oral tablet approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia. However, the clinical efficacy of Latuda... S Li,Y He,D Sun,... - 《Aaps Pharmscitech》 被引量: 0发表: 2023年 Lupin receives FDA approval for lurasidone hydrochloride tabl...
Table 1: LATUDA Tablet Presentations Tablet Strength 20 mg 40 mg 60 mg 80 mg 120 mg Tablet Color/Shape white to off-white round white to off-white round white to off-white oblong pale green oval white to off-white oval Tablet Markings L20 L40 L60 L80 L120 4 CONTRAINDICATIONS • ...
Table 1: LATUDA Tablet Presentations Storage And Handling LATUDAtablets are white to off-white, round (20 mg or 40 mg), white to off-white, oblong (60 mg), pale green, oval (80 mg) or white to off-white, oval (120 mg) and identified with strength-specific one-sided debossing, “L...
作者: 董江萍 摘要: 2010年10月28日,美国食品药品管理局(FDA)批准治疗成人精神分裂症新药Latuda(lurasidone HCl),剂型为片剂,由Sunovion Pharmaceuticals Inc.of Fort Lee,N.J.生产. 关键词: 精神分裂症;FDA批准;成人;美国食品药品管理局;新药;治疗;思想混乱;幻觉 DOI: CNKI:SUN:GWZW.0.2010-06-028 年份...
(盐酸鲁拉西酮)的新适应证,用于治疗儿科患者(10~17岁)双相I型障碍(双相抑郁)相关的重度抑郁症发作.Latuda新适应证的获批,是基于一项6周,随机,双盲,安慰剂对照Ⅲ期临床研究的数据.该研究在347例儿童及青少年(10~17岁)双相抑郁患者中开展.研究中,患者接受每日一次Latuda灵活剂量(20~80 mg/d)或安慰剂.数据显示...